Virtus ETF Advisers LLC Instil Bio, Inc. Transaction History

Virtus ETF Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $716 - $1,134	154 Added 0.72%	21,404 $104,000
Q2 2022 Aug 12, 2022	BUY	$4.21 - $11.15 $52,359 - $138,672	12,437 Added 141.12%	21,250 $98,000
Q1 2022 May 16, 2022	SELL	$8.48 - $18.1 $4,358 - $9,303	-514 Reduced 5.51%	8,813 $95,000
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $143,355 - $209,857	9,327 New	9,327 $160,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.